U.S. Physical Therapy, Inc. (USPH) Given Average Rating of “Hold” by Brokerages

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received an average recommendation of “Hold” from the six ratings firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $71.00.

A number of equities analysts have issued reports on USPH shares. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Saturday, August 26th. Barrington Research cut U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, November 3rd. Cantor Fitzgerald reiterated a “buy” rating and set a $72.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, September 26th. Sidoti upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $62.00 to $74.00 in a research note on Friday, September 8th. Finally, Jefferies Group LLC set a $65.00 target price on U.S. Physical Therapy and gave the stock a “hold” rating in a research note on Friday, August 4th.

In other news, CEO Christopher J. Reading sold 15,000 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $66.52, for a total transaction of $997,800.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Lawrance W. Mcafee sold 800 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $69.21, for a total value of $55,368.00. The disclosure for this sale can be found here. Insiders sold a total of 26,602 shares of company stock worth $1,740,976 over the last 90 days. 3.10% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in USPH. Teachers Advisors LLC increased its position in shares of U.S. Physical Therapy by 2.4% during the first quarter. Teachers Advisors LLC now owns 29,647 shares of the company’s stock valued at $1,936,000 after buying an additional 684 shares during the period. Vanguard Group Inc. increased its position in shares of U.S. Physical Therapy by 6.5% during the first quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock valued at $41,892,000 after buying an additional 39,290 shares during the period. Geode Capital Management LLC increased its position in shares of U.S. Physical Therapy by 6.0% during the first quarter. Geode Capital Management LLC now owns 91,309 shares of the company’s stock valued at $5,962,000 after buying an additional 5,130 shares during the period. Dimensional Fund Advisors LP increased its position in shares of U.S. Physical Therapy by 0.9% during the first quarter. Dimensional Fund Advisors LP now owns 482,922 shares of the company’s stock valued at $31,535,000 after buying an additional 4,361 shares during the period. Finally, BlackRock Inc. increased its position in shares of U.S. Physical Therapy by 166,319.0% during the first quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock valued at $101,501,000 after buying an additional 1,553,419 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

U.S. Physical Therapy (NYSE:USPH) opened at $70.30 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.04 and a current ratio of 2.04. The stock has a market cap of $880.68, a price-to-earnings ratio of 33.82, a price-to-earnings-growth ratio of 3.01 and a beta of 1.07. U.S. Physical Therapy has a fifty-two week low of $56.50 and a fifty-two week high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.52 by ($0.04). The firm had revenue of $103.03 million for the quarter, compared to analysts’ expectations of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. sell-side analysts anticipate that U.S. Physical Therapy will post 2.07 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Investors of record on Friday, November 17th will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Thursday, November 16th. U.S. Physical Therapy’s dividend payout ratio is currently 48.19%.

WARNING: “U.S. Physical Therapy, Inc. (USPH) Given Average Rating of “Hold” by Brokerages” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was stolen and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/12/05/u-s-physical-therapy-inc-usph-given-average-rating-of-hold-by-brokerages.html.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply